BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38297990)

  • 1. Development of an Electronic Decision Aid Tool to Facilitate Mainstream Genetic Testing in Ovarian Cancer Patients.
    Shannon KM; Patel D; Jonas JM; Blouch EL; Hicks SR; Wooters M; Seidel M; Grant CF; Emmet MM; Chung DC; Sepucha K
    Oncologist; 2024 May; 29(5):e665-e671. PubMed ID: 38297990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.
    Wakefield CE; Meiser B; Homewood J; Peate M; Taylor A; Lobb E; Kirk J; Young MA; Williams R; Dudding T; Tucker K;
    Breast Cancer Res Treat; 2008 Jan; 107(2):289-301. PubMed ID: 17333332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
    Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
    BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "Begin Exploring Fertility Options, Risks and Expectations" (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients.
    Speller B; Metcalfe K; Kennedy ED; Facey M; Greenblatt E; Scheer AS; Warner E; Joy AA; Wright FC; Baxter NN
    BMC Med Inform Decis Mak; 2019 Oct; 19(1):203. PubMed ID: 31660965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Users of Healthcare Services: Development and Alpha Testing of a Patient Decision Aid for Case Management.
    Poitras ME; Légaré F; Tremblay Vaillancourt V; Godbout I; Poirier A; Prévost K; Spence C; Chouinard MC; Zomahoun HTV; Khadhraoui L; Massougbodji J; Bujold M; Pluye P; Hudon C
    Patient; 2020 Dec; 13(6):757-766. PubMed ID: 33083997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
    Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
    BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' and Providers' Needs and Preferences When Considering Fertility Preservation Before Cancer Treatment: Decision-Making Needs Assessment.
    Hoffman A; Crocker L; Mathur A; Holman D; Weston J; Campbell S; Housten A; Bradford A; Agrawala S; Woodard TL
    JMIR Form Res; 2021 Jun; 5(6):e25083. PubMed ID: 34096871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a decision aid to support informed choices for newly diagnosed patients with localized prostate cancer.
    Chabrera C; Font A; Caro M; Areal J; Zabalegui A
    Cancer Nurs; 2015; 38(1):E55-60. PubMed ID: 24831045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
    Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
    J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.
    Mallen AR; Conley CC; Fuzzell L; Ketcher D; Augusto BM; McIntyre M; Barton LV; Townsend MK; Fridley BL; Tworoger SS; Wenham RM; Vadaparampil ST
    Support Care Cancer; 2021 May; 29(5):2663-2677. PubMed ID: 32975643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).
    Juan AS; Wakefield CE; Kasparian NA; Kirk J; Tyler J; Tucker K
    Genet Test; 2008 Dec; 12(4):523-32. PubMed ID: 19072564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy.
    van Lieshout LAM; Gelderblom ME; de Hullu JA; The R; van Ginkel AA; Oerlemans AJM; Smeets KMWH; Schreurs MPH; Piek JMJ; Hermens RPMG
    Am J Obstet Gynecol; 2022 Feb; 226(2):234.e1-234.e14. PubMed ID: 34536392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decision aid for women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Reeson E; Tucker M; Andrews L; Gaff C; Kirk J; Phillips KA; Friedlander M
    Int J Gynecol Cancer; 2003; 13(1):15-22. PubMed ID: 12631214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.
    Sobocan M; Chandrasekaran D; Sideris M; Blyuss O; Fierheller C; Kalra A; Sia J; Miller RE; Mills-Baldock T; Crusz SM; Sun L; Evans O; Robbani S; Jenkins LA; Ahmed M; Kumar A; Quigley M; Lockley M; Faruqi A; Casey L; Brockbank E; Phadnis S; Trevisan G; Singh N; Legood R; Manchanda R
    BJOG; 2024 May; 131(6):848-857. PubMed ID: 37752678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision aids for people facing health treatment or screening decisions.
    Stacey D; Légaré F; Col NF; Bennett CL; Barry MJ; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L; Wu JH
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001431. PubMed ID: 24470076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Testing of a Decision Aid for Unaffected Women with a BRCA1 or BRCA2 Mutation.
    Jabaley T; Underhill-Blazey ML; Berry DL
    J Cancer Educ; 2020 Apr; 35(2):339-344. PubMed ID: 30661232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ask the parents: Testing the acceptability and usability of a hypospadias decision aid.
    Binion K; Miller A; Misseri R; Kaefer M; Longtin K; Carroll A; Wiehe SE; Chan KH
    J Pediatr Urol; 2022 Apr; 18(2):170.e1-170.e9. PubMed ID: 35131196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DECIDE: a Decision Support Tool to Facilitate Parents' Choices Regarding Genome-Wide Sequencing.
    Birch P; Adam S; Bansback N; Coe RR; Hicklin J; Lehman A; Li KC; Friedman JM
    J Genet Couns; 2016 Dec; 25(6):1298-1308. PubMed ID: 27211035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled Trial.
    Krishnamurti L; Ross D; Sinha C; Leong T; Bakshi N; Mittal N; Veludhandi D; Pham AP; Taneja A; Gupta K; Nwanze J; Matthews AM; Joshi S; Vazquez Olivieri V; Arjunan S; Okonkwo I; Lukombo I; Lane P; Bakshi N; Loewenstein G
    J Med Internet Res; 2019 Dec; 21(12):e14462. PubMed ID: 31799940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.
    Grimmett C; Brooks C; Recio-Saucedo A; Armstrong A; Cutress RI; Gareth Evans D; Copson E; Turner L; Meiser B; Wakefield CE; Eccles D; Foster C
    Support Care Cancer; 2019 Jan; 27(1):297-309. PubMed ID: 29955974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.